Olivier Sitbon Selected Research

Olivier Sitbon Research Topics

Disease

117	Pulmonary Arterial Hypertension 01/2022 - 03/2002
42	Pulmonary Hypertension 01/2022 - 03/2002
14	Familial Primary Pulmonary Hypertension 01/2020 - 02/2002
10	Connective Tissue Diseases (Connective Tissue Disease) 01/2020 - 07/2006
9	Disease Progression 01/2022 - 06/2004
8	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2021 - 03/2002
8	Hypertension (High Blood Pressure) 01/2020 - 01/2006
7	Congenital Heart Defects (Congenital Heart Defect) 01/2020 - 06/2005
7	HIV Infections (HIV Infection) 10/2013 - 12/2004
6	Hypoxia (Hypoxemia) 01/2021 - 06/2009
6	Heart Failure 12/2017 - 08/2002
4	Headache (Headaches) 10/2021 - 10/2008
4	Neoplasms (Cancer) 10/2021 - 07/2010
4	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2021 - 08/2011
4	Systemic Scleroderma (Systemic Sclerosis) 08/2016 - 03/2010
4	Infections 04/2016 - 11/2008
3	Nausea 10/2021 - 10/2008
3	Vascular Remodeling 10/2021 - 12/2005
3	Pleural Effusion (Pleural Effusions) 10/2020 - 03/2002
3	Rare Diseases (Rare Disease) 01/2019 - 09/2015
3	Sarcoidosis (Schaumann Disease) 10/2017 - 11/2015
3	Pain (Aches) 12/2015 - 06/2004
3	Portal Hypertension 08/2010 - 11/2008
2	Diarrhea 10/2021 - 12/2015
2	Inflammation (Inflammations) 01/2021 - 10/2013
2	Eisenmenger Complex (Eisenmenger's Syndrome) 05/2017 - 04/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 05/2012
2	Clinical Deterioration 11/2013 - 08/2002
2	Hereditary Hemorrhagic Telangiectasia 04/2010 - 12/2005
2	Lymphadenopathy 01/2010 - 03/2002
2	Pulmonary Edema 08/2009 - 07/2008
2	Dyspnea (Shortness of Breath) 10/2008 - 08/2002
2	Mixed Connective Tissue Disease (MCTD) 02/2008 - 07/2006
1	Bronchiolitis Obliterans 10/2021
1	Hodgkin Disease (Hodgkin's Disease) 10/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021
1	Respiratory Insufficiency (Respiratory Failure) 10/2021
1	Cystic Fibrosis (Mucoviscidosis) 01/2021
1	Pulmonary Embolism 01/2021

Drug/Important Bio-Agent (IBA)

31	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021 - 02/2002
17	Endothelin Receptor AntagonistsIBA 01/2020 - 07/2003
13	macitentanIBA 01/2022 - 08/2013
13	selexipagIBA 01/2022 - 12/2015
12	Bosentan (Tracleer)FDA Link 01/2013 - 07/2003
11	Pharmaceutical PreparationsIBA 10/2021 - 06/2004
9	Vasodilator Agents (Vasodilators)IBA 01/2019 - 02/2002
6	ProstaglandinsIBA 01/2022 - 09/2002
6	Endothelins (Endothelin)IBA 12/2012 - 06/2004
5	Epoprostenol ReceptorsIBA 01/2022 - 12/2015
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2012
5	Dasatinib (BMS 354825)FDA Link 10/2020 - 05/2012
5	Phosphodiesterase 5 InhibitorsIBA 01/2020 - 09/2009
5	Sildenafil Citrate (Viagra)FDA Link 01/2014 - 10/2008
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013 - 06/2002
4	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2016 - 06/2008
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2013 - 06/2005
3	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2017
3	ProteomeIBA 01/2022 - 01/2017
3	Tadalafil (Cialis)FDA Link 10/2021 - 09/2009
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 10/2014
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2005
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2021 - 09/2015
3	treprostinil FDA Link 01/2020 - 01/2007
3	InterferonsIBA 01/2016 - 12/2014
3	Appetite Depressants (Anorectics)IBA 10/2011 - 11/2008
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2019
2	Phosphotransferases (Kinase)IBA 10/2021 - 01/2018
2	Carbon MonoxideIBA 01/2021 - 01/2010
2	riociguatIBA 01/2021 - 12/2015
2	MonocrotalineIBA 01/2021 - 11/2010
2	bosutinibIBA 10/2020 - 11/2016
2	Imatinib Mesylate (Gleevec)FDA Link 10/2020 - 01/2016
2	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2018 - 02/2016
2	Prostaglandins IIBA 04/2016 - 01/2016
2	DiureticsIBA 07/2013 - 06/2009
2	FenfluramineIBA 11/2012 - 06/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2008 - 07/2006
2	Immunosuppressive Agents (Immunosuppressants)IBA 02/2008 - 07/2006
2	beraprostIBA 06/2004 - 05/2002
1	Busulfan (Busulfex)FDA Link 10/2021
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 10/2021
1	Macrophage Colony-Stimulating FactorIBA 10/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021
1	Soluble Guanylyl CyclaseIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Growth Factor ReceptorsIBA 01/2021
1	Xanthine OxidaseIBA 01/2021
1	Uric Acid (Urate)IBA 01/2021

Therapy/Procedure

58	Therapeutics 01/2022 - 03/2002
7	Lung Transplantation 01/2022 - 09/2002
6	Liver Transplantation 01/2020 - 09/2014
6	Transplantation 01/2020 - 03/2006
5	Endarterectomy (Thromboendarterectomy) 01/2021 - 04/2007
5	Drug Therapy (Chemotherapy) 01/2019 - 01/2015
4	Contraindications 01/2020 - 01/2006
4	Highly Active Antiretroviral Therapy (HAART) 10/2013 - 09/2008
3	Aftercare (After-Treatment) 10/2021 - 07/2008
2	Heart-Lung Transplantation 08/2017 - 10/2014
2	Intravenous Infusions 04/2016 - 05/2002